The biotechnology company EQRx no longer seeks to disrupt prices in the non-small cell lung cancer space. This is disappointing news for those who had hoped for lower prices in a therapeutic category that, for the most part, has been sorely lacking rea…
The pharma industry’s global reach and scale is unparalleled. What’s at stake here isn’t just corporate profitability, but access to trials to improve the quality and duration of life for patients desperately in search of new cures.
People with Covid reinfections were twice as likely to die and three times more likely to be hospitalized compared to people with just one infection, researchers found.
Until the development of long-lasting, “universal” coronavirus vaccines, our best strategy for protection against infection, hospitalization, and death is staying up to date with our booster shots.